Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.22847 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.20452 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21777 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15747 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.13517 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.2581 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.2181 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.09026 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.52659 | 86 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18314 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17243 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.18223 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.19936 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.1929 | 50 |